Biological Formulations
APT and iDPC have the capabilities to tackle the most challenging biological projects, whether low or high dose, heat or moisture sensitive.
iDPC provides a simpler route to developing biological formulations and preserves the properties of APIs through its low shear, no attrition, no heat or solvent requirement for controllable and precise micro/nano particle engineering
APT has a patented and proven method, iDPC, to address the unique challenges presented by biologicals and protein drugs.
- No evidence of degradation/denaturation of biologics
- No particle attrition, no chemical modification during processing
- Biologicals can be the carrier or the guest material – iDPC conserves biological activity
- Potential coformulation development of biologicals for combination therapy
